VS
V SrivatsaFund Manager Since 3 Mar 2017
EquitySector - Healthcare
UTI Healthcare Fund Regular Plan Growth
3Y Annualised
25.78%
1.58% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
0.60%
1.58% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
This Fund
3 years
NIFTY 50
5 years 9 months
FD
9 years 7 months
Fund info
Fund size
₹1106.71 Cr
Min. SIP amount
₹500
Min. Lumpsum amount
₹5000
Exit load
0.01%
Period of Holding < 30 - 1%, Period of Holding = 30 days - Nil
Risk Profile
Very High Risk
Peer Comparison
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
Mirae Asset Healthcare Fund Direct Reinvestment of Income Distribution cum capital withdrawal
5.39%
2nd
Mirae Asset Healthcare Fund Direct Payout of Income Distribution cum capital withdrawal
5.39%
3rd
Mirae Asset Healthcare Fund Direct Growth
5.38%
4th
Mirae Asset Healthcare Fund Regular Growth
5.27%
5th
Mirae Asset Healthcare Fund Regular Payout of Income Distribution cum capital withdrawal
5.26%
94th
UTI Healthcare Fund Regular Plan Growth
0.60%
Fund Managers
KG
Kamal GadaFund Manager Since 2 May 2022
About UTI Healthcare Fund Regular Plan Growth
UTI Healthcare Fund Regular Plan Growth is a Equity mutual fund scheme from UTI Asset Management Co Ltd. This fund has been in existence for 26 years, having been launched on 1999-06-28. UTI Healthcare Fund Regular Plan Growth has ₹1106.71 Cr worth of assets under management (AUM) as of Wed Mar 11 2026. The latest Net Asset Value (NAV) of UTI Healthcare Fund Regular Plan Growth as of Tue Mar 10 2026 is ₹282.415. The fund has an expense ratio of 2.28%, which is medium comparable to most other Equity funds.
UTI Healthcare Fund Regular Plan Growth returns for the last 1 year are 10.43%. Since launch, it has delivered 14.52% average annual returns.
The UTI Healthcare Fund Regular Plan Growth has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of UTI Healthcare Fund Regular Plan Growth.
- Sun Pharmaceuticals Industries Ltd: 9.42%
- Ajanta Pharma Ltd: 7.04%
- Lupin Ltd: 5.79%
- Glenmark Pharmaceuticals Ltd: 4.25%
- Apollo Hospitals Enterprise Ltd: 3.75%
AMC Information
| Name | UTI Asset Management Co Ltd |
|---|---|
| Founding Date | 1999-06-28 |
| pms_care@uti.co.in | |
| Phone | +91-22-6678 6666 |
| Website | https://www.utiwms.com |
| Address | PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051 |
Tax Implications of UTI Healthcare Fund Regular Plan Growth
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from UTI Asset Management Co Ltd
UTI Conservative Hybrid Fund Regluar Plan Growth
AllocationConservative Allocation
3Y CAGR
9.29%
expense ratio
1.81%
fund size
₹1680.67 Cr
UTI MNC Fund Regular Plan Growth
EquityEquity - Other
3Y CAGR
12.24%
expense ratio
2.04%
fund size
₹2723.74 Cr
UTI Large cap Fund Regular Plan Growth
EquityLarge-Cap
3Y CAGR
11.68%
expense ratio
1.75%
fund size
₹12658.21 Cr
UTI Mid Cap Fund Regular Plan Growth
EquityMid-Cap
3Y CAGR
16.41%
expense ratio
1.76%
fund size
₹11734.39 Cr
UTI Value fund Fund-Direct Growth Option
EquityValue
3Y CAGR
18.16%
expense ratio
1.19%
fund size
₹9787.26 Cr
Calculate Your Returns
Estimated Returns in 3 Years (Based on past 3Y returns)
₹0
Total Amount
₹0
